Evidence map›Paper›PMID 36047595›Full record

ArticleTurkish journal of pharmaceutical sciences2022

Multidrug-Resistant and Extremely Drug-Resistant

Amaka Marian Awanye, Chidozie Ngozi Ibezim, Catherine Nonyelum Stanley, Hannah Onah, Iheanyi Omezurike Okonko, Nkechi Eucharia Egbe

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Case Report: Pan-Drug ResistantInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amaka Marian AwanyeUniversity of Port Harcourt, Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Microbiology and Biotechnology, Rivers, Nigeria.ORCID 0000-0003-4693-3722
Chidozie Ngozi IbezimUniversity of Port Harcourt, Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Microbiology and Biotechnology, Rivers, Nigeria.ORCID 0000-0002-1009-6857
Catherine Nonyelum StanleyUniversity of Port Harcourt, Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Microbiology and Biotechnology, Rivers, Nigeria.ORCID 0000-0002-6226-9182
Hannah OnahUniversity of Port Harcourt, Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Microbiology and Biotechnology, Rivers, Nigeria.ORCID 0000-0001-6437-793X
Iheanyi Omezurike OkonkoUniversity of Port Harcourt, Faculty of Sciences, Department of Microbiology, Rivers, Nigeria.ORCID 0000-0002-3053-253X
Nkechi Eucharia EgbeNigerian Defence Academy, Faculty of Science, Department of Biotechnology, Kaduna, Nigeria.ORCID 0000-0003-0086-2172
University of Port Harcourt · NGNigerian Defence Academy · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Materials and Methods: Clinical samples, namely blood, urine, tracheal aspirate, cerebrospinal fluid (CSF), wound swabs, high vaginal swabs, eye, and ear exudates were obtained from patients, processed and identified using standard microbiological protocols. Antibiotic susceptibility testing was undertaken using the Kirby Bauer Disc diffusion method. Results were reported following the Clinical and Laboratory Standards Institute guidelines. Results: Of 104 Conclusion: The study recorded alarmingly high cases of MDR and some XDR phenotypes of

Indexed as

Antibioticsantimicrobial resistanceextremely drug resistancemultidrug resistanceNigeriaPseudomonas aeruginosa

Identifiers

PMID36047595
PMCPMC9438764
OpenAlexW3205541365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.